ΨΥΧΟΛΟΓΙΑ - Έρευνα και Εφαρμογές ΤΕΥΧΟΣ 3 | Page 14

«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
34. Review and meta-analysis of antidepressant pharmacogenetic findings in major
depressive disorder, 04 November 2008, M Kato & A Serretti, Molecular Psychiatry
volume 15, pages 473–500 (2010)
35. Feature Review | Published: 23 March 2004 Influence of SERTPR and STin2 in
the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors
in depression: a systematic review K M Smits, L J M Smits, J S A G Schouten, F F
Stelma, P Nelemans & M H Prins Molecular Psychiatry volume 9, pages 433–441
36. Association study of the serotonin transporter promoter polymorphism and
symptomatology and antidepressant response in major depressive disorders Y W-Y
Yu, S-J Tsai, T-J Chen, C-H Lin & C-J Hong . Molecular Psychiatry volume 7,
pages 1115–1119 (2002)
37. Analysis of Association Between the Serotonin Transporter and Antidepressant
Response in a Large Clinical Sample Jeffrey B.Kraft Eric J.Peters Susan L.Slagerb
Greg .Jenkins Megan S.Reinalda Patrick J.McGrath Steven P.Hamilton
38. Meta-analysis of serotonin transporter gene promoter polymorphism (5-
HTTLPR) association with selective serotonin reuptake inhibitor efficacy in
depressed patients A Serretti, M Kato, D De Ronchi & T Kinoshita Molecular
Psychiatry volume 12, pages 247–257 (2007)
39 Clinical Implementation of Pharmacogenetic Decision Support Tools for
Antidepressant Drug Prescribing Zane Zeier , Ph.D., Linda L. Carpenter , M.D., Ned
H. Kalin , M.D., Carolyn I. Rodriguez , M.D., Ph.D., William M. McDonald , M.D., Alik
S. Widge , M.D., Ph.D., Charles B. Nemeroff . The American journal of psychiatry
25 Apr 2018
40. Pharmacogenetics in Psychiatry: A Companion, Rather Than Competitor, to
Protocol-Based Care—Reply . George S. Zubenko, MD, PhD Barbara R. Sommer,
MD Bruce M. Cohen, MD, PhD JAMA Psychiatry. 2018;75(10):1090-1091.
41. Clinical utility of pharmacogenetic testing in schizophrenia treatment Daniel
Mueller, Arun Tiwari, Clement Zai, and James Kennedy Schizophr Bull. 2018 Apr;
44(Suppl 1): S412.
42. Pharmacogenetic tests to guide drug treatment in depression: Comparison of
the available testing kits and clinical trials. ChiaraFabbria Joseph Zoharb
AlessandroSerretti, Progress in Neuro-Psychopharmacology and Biological
Psychiatry Volume 86, 30 August 2018, Pages 36-44.
43. Psychiatric Pharmacogenomics: How Close Are We? Matthew E. Hirschtritt,
Aaron D. Besterman, and David A. Ross. Biol Psychiatry. 2016 Oct 15; 80(8): e63–
e65.
44. SLC6A4 variation and citalopram response. Mrazek DA1, Rush AJ, Biernacka
JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL,
Snyder KA, Black JL 3rd, Weinshilboum RM. Am J Med Genet B Neuropsychiatr
Genet. 2009 Apr 5;150B(3):341-51
45. Schizophrenia, Siegfried Kasper, George N. Papadimitriou, page 329